WuXi AppTec

Rising Geopolitical And Regulatory Pressures Will Crash Profits

AnalystLowTarget

Not Invested

Consensus Narrative from 18 Analysts

Published

03 Aug 25

Updated

27 Aug 25

AnalystLowTarget's Fair Value

CN¥89.70

6.7% overvalued

27 Aug

CN¥95.69

147.2%

4.4%

147.2%

4.4%

Author's Valuation

CN¥89.7

6.7% overvalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

CN¥89.7

6.7% overvalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

11.24%

Life Sciences revenue growth rate

0.32%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.32%

Calculation

CN¥16.25b

Earnings '28

28.69x

PE Ratio '28

CN¥466.15b

Market Cap '28

CN¥466.15b

Market Cap '28

4.20b

No. shares '28

CN¥110.89

Share Price '28

CN¥110.89 Share Price '28

Discounted to 2025 @ 7.32% p.a.

CN¥89.71

Fair Value '25